Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4066 to 4080 of 8931 results

  1. Medicines associated with dependence or withdrawal symptoms. Patient decision aid full version on should I stop my benzodiazepine or z-drug?

    Should I stop my benzodiazepine or z-drug? This decision aid can help if you have been prescribed a benzodiazepine or z-drug for anxiety or sleeping...

  2. Type 2 diabetes in adults. Patient decision aid on type 2 diabetes: agreeing my blood glucose (HbA1c) target

    1 Type 2 diabetes: agreeing my blood glucose (HbA1c) target Patient decision aid c NICE 2022. All rights reserved. Subject to Notice of rights. Last...

  3. Evidence summaries: new medicines – Integrated process statement (PMG11)

    This integrated process statement has been produced to explain how 'Evidence summaries: new medicines' (ESNMs) are developed. It provides an overview of the key process principles and describes all stages of the development of ESNMs

  4. Good practice guidance – Integrated process statement (PMG12)

    This process statement has been produced to explain how good practice guidance is developed. It provides an overview of the key process principles and describes all stages of the development of good practice guidance

  5. Evidence summaries: unlicensed and off-label medicines – Integrated process statement (PMG14)

    This integrated process statement has been produced to explain how 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs) are developed. It provides an overview of the key process principles and describes all stages of development for ESUOMs

  6. Evidence summaries: new medicines – Interim process statement (PMG1)

    This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

  7. Methods for the development of NICE public health guidance (third edition) (PMG4)

    This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance

  8. Cost comparison timeline

    These are the main stages in the multiple technology appraisal process used before April 2018.

  9. Timeline for developing quality standards

    The key stages in development of our quality standards

  10. About evidence summaries

    Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

  11. Public board meeting agenda and papers: December 2023

    Agenda and papers of the NICE public board meeting on 13 December 2023

  12. Public board meeting agenda and papers: December 2022

    Agenda and papers of the NICE public board meeting on 16 December 2022

  13. Supporting parents

    Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings {"@context":"http://schema

  14. Maintaining contact with service users

    Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services {"@context":"http://schema.org"

  15. Methods research areas

    NICE priority methodological research areas.